The current situation and future aspects of cost-effectiveness in chronic myeloid leukemia treatment

Leuk Lymphoma. 2015 May;56(5):1554-5. doi: 10.3109/10428194.2014.975701. Epub 2014 Nov 19.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cost-Benefit Analysis*
  • Female
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / epidemiology*
  • Male